Cannabigerol (CBG) is a non-psychoactive compound produced by cannabis plants, though usually only in trace amounts. Scientists refer to CBG as the “stem cell of cannabinoids,” as it is the precursor to CBD, THC, CBC, and other minor compounds. Pure CBG plants can be isolated by skilled breeders, but–until now–have not been commercially available anywhere in the world. We believe it is one of nature’s truly rare gifts and are ecstatic to be the first to provide it to consumers.

Our seed genetics team has worked for 3 years to create high cannabinoid content, CBG predominant plants (Type IV) using traditional breeding techniques at their federally-legal industrial hemp research facility in Oregon. The result is a very special plant whose cannabinoid profile is 99.5% CBG. There is so little THC produced by this rare hemp plant that many of our concentrated products remain below the federal limit (0.3%), which allows us to ship a wide range of products to customers anywhere in the US and many other countries internationally. We are convinced that its usefulness as a daily dietary supplement will eventually surpass both CBD and THC.

Researchers have demonstrated that CBG is:

• Strongly anti-bacterial. Appendino et al. (2008) found that it is a promising front line treatment for  methicillin-resistant staphylococcus aureus (MRSA).
• Anti-psoriasis and eczema. Wilkinson and Williamson (2007) found that CBG inhibits human keratinocyte proliferation through novel cannabinoid receptors located in our skin (i.e. not CB1 or CB2 receptors).
• Powerfully anti-inflammatory. Borrelli et al. (2013) investigated the usefulness of CBG for treatment of Inflammatory Bowel Disease (IBS) and found significant improvement in test subjects (mice).
• Potent neuropathic pain suppressor. Russo (2008) reports that the binding mechanism of CBG suggests novel analgesic properties that should work better than THC for pain and spasticity control.
• Neuroprotective. Valdeolivas et al. (2014) established that CBG improved motor deficits and preserved striatal neurons in mice with induced Huntington’s disease. The findings suggest that other neurodegenerative diseases (Alzheimer’s, Parkinson’s, etc.) may respond well to increased CBG intake.
• Promotes Neurogenesis. Not only does it protect neurons, CBG has the ability to stimulate the growth of new neuronal cells. Diaz-Alonso et al. (2016) have taken this one step further and created a synthetic compound derived from CBG to make a very efficient new drug that is slightly more effective than plant-derived cannabigerol as a “neuronal progenitor”. We applaud their efforts, but prefer the herbal form.

We are releasing a small amount of CBG flowers and extraction material for the 2019 season.